Refresh
Gainers Losers Sectors Indices Forex Mutual Funds

Dr. Reddy's Laboratories Ltd.

Price on BSE   12 Aug,15:51 LIVE
1,198.95
-6.05
(-0.50%)

© 2026 Rediff.com
  • Volume :
  • 95,446.00
  • Prev Close :
  • 1,205.00
  • Day's H/L (Rs.) :
  • 1,206.00 - 1,190.00
  • 52wk H/L (Rs.) :
  • 1,414.40 - 1,080.05
  • Mkt Cap (Rs. Cr) :
  • 100,076.36
Price on NSE   12 Aug,15:59 LIVE
1,200.00
-5.00
(-0.41%)

© 2026 Rediff.com
  • Volume :
  • 2,366,909.00
  • Prev Close :
  • 1,205.00
  • Day's H/L (Rs.) :
  • 1,206.80 - 1,190.00
  • 52wk H/L (Rs.) :
  • 1,414.90 - 1,101.00
  • Mkt Cap (Rs. Cr) :
  • 0.00

View more

Market News

Indian drugmakers in no rush to shift to US despite tariff threat
Rediff.com   1 day(s) ago
Dr Reddy's Labs plunges 69% to Rs 443 crore, hit by lenalidomide exit and semaglutide issues
Rediff.com   23 Jul 2026
Q1 Earnings, West Asia Tensions, Crude Oil to Drive Market Movement This Week
Rediff.com   19 Jul 2026
Indian Pharma Bets Beyond US Generics
Rediff.com   26 Jun 2026
Report Card - Dr. Reddy's Laboratories Ltd.
PE Ratios
31.25
EPS (Rs.)
38.56
Sales (Rs. Cr)
5,136.60
Face Value (Rs.)
1
Net Profit Margin(%)
15.68
Last Bonus
1:1
Last Dividend(%)
800
Return on Average Equity
10.26

News for Dr. Reddy's Laboratories Ltd.

Dr Reddy''s Launches Generic Sugammadex Injection in US
Dr Reddy''s launches generic Sugammadex injection in the US, offering an affordable alternative to Bridion for reversing muscle relaxants during surgery.
Aug 04, 2026 13:33
Dr Reddy''s shares tumble 9% post-Q1 earnings, hit 52-week low
Dr Reddy''s shares plunged nearly 9% to a 52-week low after Q1 net profit fell 69.2%. Semaglutide API issues and generics revenue dip cited.
Jul 23, 2026 11:00
Dr Reddy''s CEO: US Tariffs Will Hike Drug Prices
Dr Reddy''s CEO Erez Israeli warns US tariffs on generic medicines will lead to higher drug prices. India, a major exporter, will be impacted by Trump''s plan.
Jul 22, 2026 19:03
Dr Reddy''s Q1 Profit Plunges 69.2% Amid Semaglutide Issue
Dr Reddy''s Q1 net profit fell 69.2% to Rs 434.8 cr, impacted by semaglutide ingredient provisions & North America generics dip. Revenue also declined.
Jul 22, 2026 17:19
US Tariffs on Generic Drugs: India''s Pharma Exports at Risk
GTRI warns US tariffs on generic medicines could significantly impact India''s largest pharma export market. Trump''s plan aims to reshore production, affecting Indian companies.
Jul 22, 2026 14:24

More News for Dr. Reddy's Laboratories Ltd. »

About Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology. Wikipedia

News for Pharmaceuticals

Tata Group Stocks Drop; TCS Tumbles on Chairman''s Exit
Tata Group stocks, including TCS, fell sharply after N Chandrasekaran announced he won''t seek reappointment as Tata Sons Chairman in 2027, impacting market valuation.
Aug 12, 2026 17:17
Sensex Falls Amid High Crude, Tata Stocks Decline on Chandra Exit
Indian Sensex falls 188 points as elevated crude oil prices and selling in Tata Group stocks, including TCS, after N Chandrasekaran''s exit announcement, weigh on markets.
Aug 12, 2026 17:04
Senco Gold Q1FY27 Profit Dips 3% Despite Strong Revenue Growth
Senco Gold''s Q1FY27 net profit fell 3% to Rs 101 crore, impacted by high gold prices, despite a 67% revenue jump. Margins contracted.
Aug 12, 2026 16:47
Inflation Inches Up to 4.45% in July: Govt Data
India''s retail inflation climbed to 4.45% in July, up from 4.38% in June, primarily due to surging food prices. NSO data highlights RBI''s ongoing concerns.
Aug 12, 2026 16:22
Coal India, AMNS Pact for Syn-Gas Utilisation at Paradip
Coal India & AMNS sign pact for synthesis gas utilisation from a coal gasification plant at Paradip, Odisha. Boosts clean energy & reduces imports.
Aug 12, 2026 16:15

More News »

Top News

Indel Money to Raise Rs 500 Cr via NCD Public Issue
Indel Money, a non-banking finance company, plans to raise up to Rs 500 crore through a public issue of NCDs. The issue opens Aug 18 for onward lending.
Aug 12, 2026 17:20
BRICS Oceanic-Polar Science & Tech Meeting Begins in Goa
Goa hosts the 8th BRICS Working Group meeting on Oceanic and Polar Science and Technology. Scientists from 8 nations discuss cooperation, research, and future programs.
Aug 12, 2026 17:19
Tata Group Stocks Drop; TCS Tumbles on Chairman''s Exit
Tata Group stocks, including TCS, fell sharply after N Chandrasekaran announced he won''t seek reappointment as Tata Sons Chairman in 2027, impacting market valuation.
Aug 12, 2026 17:17
Sensex Falls Amid High Crude, Tata Stocks Decline on Chandra Exit
Indian Sensex falls 188 points as elevated crude oil prices and selling in Tata Group stocks, including TCS, after N Chandrasekaran''s exit announcement, weigh on markets.
Aug 12, 2026 17:04
N. Chandrasekaran Resigns: Tata Sons Chairman''s Decade Legacy
Natarajan Chandrasekaran, credited with stabilizing Tata Sons, resigns after a decade. His tenure saw expansion, new ventures, and boardroom clashes.
Aug 12, 2026 16:57

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com